# Eosinophilic Esophagitis Steroid Safety Study

> **NCT04416217** · — · COMPLETED · sponsor: **Rabin Medical Center** · enrollment: 55 (actual)

## Conditions studied

- Eosinophilic Esophagitis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04416217
- **Lead sponsor:** Rabin Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-07
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2025-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04416217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04416217, "Eosinophilic Esophagitis Steroid Safety Study". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04416217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*